United States: Mass Tort Litigation Funder Indicted In Pelvic Mesh Litigation

Last Updated: July 3 2019
Article by James Beck

We've blogged a number of times about how litigation funding arrangements involving personal injuries and mass torts collide with various ethical and statutory obligations owed by either the funders or the lawyers they fund. These all involve United States litigation. But when the New York Times reported on the questionable funding arrangements that have occurred in Pelvic Mesh litigation in its 2018 article, "How Profiteers Lure Women Into Often-Unneeded Surgery," we knew that something more was going on. Since, as the article revealed, "[p]eople are claiming the Fifth," then an investigation of possible criminal activity was a definite possibility.

Now that's happened.

Last month, the United States Attorney's office in the Eastern District of New York (that's Brooklyn) dropped a major indictment against a surgeon and a personal injury litigation funder concerning some of the misconduct reported in the New York Times. United States v. Barber, No. 1:2019cr00239 (filed May 23, 2019) (docket on PACER here).

The surgeon allegedly performed procedures on Pelvic Mesh plaintiffs that were solely for the purpose of increasing the settlement value of their product liability lawsuits over their mesh implants. Indictment ¶¶1, 5(a), 5(c). The surgeon also "paid kickbacks and bribes in exchange for . . . referral of patients." Id. ¶5(d). The indictment also recites dates, and amount of the payments for, three of the fraudulent surgeries.

The indicted funder allegedly "facilitated the coordination of removal surgeries and purchased and resold [the plaintiffs'] medical debts for profit." This defendant appears to be the key to how this personal injury scam operated.


[T]he conspiracy facilitated the identification of victims − women throughout the United States who had the mesh insert . . . and might have been willing to undergo removal surgeries and commence lawsuits against the manufacturer of the mesh.

Indictment ¶5(a). It will be interesting to find out exactly how this "identification" occurred. Medical records are confidential under federal law (HIPAA), and deliberate violation of this confidentiality could be a whole new area of criminal charges.


Once the Victims were identified, individuals associated with medical funding facilitators . . . contacted the Victims to determine whether the Victims would . . . undergo removal surgeries. To entice the Victims to undergo a removal surgery that would lead to a higher settlement payment . . . , the defendants, together with others, falsely and fraudulently (i) described the risks of the [mesh] implants and the need for removal of the [mesh] implants, (ii) strongly implied that the women would need to travel out of state to use pre-selected doctors . . ., and (iii) misled the Victims about their ability (or inability) to rely upon their health insurance to cover any medical expenses associated with the removal surgery.

Id. So the indicted funder, according to the indictment: (1) scared these would-be plaintiffs by exaggerating the risk of the mesh, (2) told them that their personal injury lawsuits would be worth more with an explant, (3) encouraged them to hide what they were doing from their real doctors and health insurers, and (4) set them up with "pre-selected" surgeons who could be relied on – for a fee − to say what was necessary to maximize the settlement payout.


[The funder defendant] financed the removal surgeries for the Victims, either through Contingent Loans or by purchasing Medical Debts. Certain agreements entered into by the Victims included provisions in which the women agreed to repay the costs of the removal surgery plus interest, which accrued at exorbitant rates, if the women ultimately received a settlement or favorable judgment against the mesh manufacturer. In certain funding arrangements, the Victims were responsible for the medical bills associated with the removal surgeries even if they did not receive a settlement.

Indictment ¶5(b). Funding personal injury litigation by way of usurious "contingent loans"? Where have we heard that before? Try Colorado and Kentucky. Oasis Legal Finance Group, LLC v. Coffman, 361 P.3d 400 (Colo. 2015); Boling v. Prospect Funding Holdings, LLC, ___ F. Appx. ___, 2019 WL 1858506 (6th Cir. April 25, 2019). See also National Football League Players' Concussion Injury Litigation, 923 F.3d 96, 112 (3d Cir. 2019) (mentioning "issues of unconscionability, fraud, or usury based on the high effective interest rates in the agreements"). And these are just the ones we know about. Personal injury funders have fought tooth and nail against disclosure requirements that could expose, and thus prevent, this kind dirty deeds (not done dirt cheap) from happening in the first place.


[O]nce surgical funding was secured, the Victims were contacted again and arrangements were made for the women to travel to visit a doctor who would perform the removal surgery (often by traveling hundreds of miles and with very little consultation in advance of the surgery).

Indictment ¶5(c).

These alleged facts give rise to the following criminal charges: (1) Wire fraud conspiracy – yes, emails count even though "wires" are anachronistic; (2) Wire fraud – three counts, one for each of the "victims" mentioned in the indictment. (3) Travel Act conspiracy – inducing the "victims" to cross state lines for "unlawful" purposes; and (4) Travel Act violation – the "bribes and kickbacks" paid to facilitate the surgeries.

Really, though, aren't the mesh manufacturers also "victims"? There has to be money in the first place, before the conspiracy could connive to steal it. The manufacturers are the ones intended to pay out inflated settlements that provided "money and property" that these alleged crooks ultimately "obtained." Id. ¶9.

In addition the government is seeking criminal forfeiture of all "proceeds" of the above criminal activity "obtained directly or indirectly." Id. ¶¶12-14. Apropos of the prior paragraph, if there is to be forfeiture, then any money that the indicted funder received that was contingent on a manufacturer settlement ought to be returned to the manufacturers, since they were the ones that these activities actually cheated. The supposed personal injury plaintiff "victims" just went along for the ride, hoping for a bigger payout for themselves.

According to the PACER docket, both of the defendants were arrested on May 24, 2019.

To add insult to the public's injury, the indicted funder now claims to be impecunious and had a public defender appointed. See PACER Docket #5 (described as "Rule 5(c)(3) documents received"). Where did all the money mentioned in the New York Times article go? If we had mandatory disclosure of litigation funding agreements, then we might know, but we don't. It will take these criminal proceedings (including forfeiture) to track it down.

We doubt that all personal injury and mass tort litigation funders engage in making usurious loans under false pretenses, as alleged here. But to prevent such abuses, routine disclosure of these arrangements – along the lines of proposals currently under consideration (see our prior post here) is essential. The disinfecting power of transparency would go a long way to preventing a recurrence of what happened here.

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions